Alterations in aortic cellular constituents during thoracic aortic aneurysm development: Myofibroblast-mediated vascular remodeling

American Journal of Pathology

Volumn 175, Issue 4, 2009, Pages 1746-1756

  Jones, Jeffrey A ^a,b   Beck, Christy ^a   Barbour, John R ^a   Zavadzkas, Jouzas A ^a   Mukherjee, Rupak ^a   Spinale, Francis G ^a,b   Ikonomidis, John S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; COLLAGEN; ELASTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SMOOTH MUSCLE FIBER; THORACIC AORTA ANEURYSM;

EID: 73549100665     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.081141     Document Type: Article

References (49)

1. Coady MA, Rizzo JA, Goldstein LJ, Elefteriades JA: Natural history, pathogenesis, and etiology of thoracic aortic aneurysms and dissections. Cardiol Clin 1999, 17:615-635
2. Isselbacher EM: Thoracic and abdominal aortic aneurysms. Circulation 2005, 111:816-828
3. Barbour JR, Spinale FG, Ikonomidis JS: Proteinase systems and thoracic aortic aneurysm progression. J Surg Res 2007, 139:292-307
4. Koullias GJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA: Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 2004, 78:2106-2110; discussion 2110-2101
5. Dingemans KP, Teeling P, Lagendijk JH, Becker AE: Extracellular matrix of the human aortic media: an ultrastructural histochemical and immunohistochemical study of the adult aortic media. Anat Rec 2000, 258:1-14
6. Wolinsky H, Glagov S: A lamellar unit of aortic medial structure and function in mammals. Circ Res 1967, 20:99-111
7. Jacob MP, Badier-Commander C, Fontaine V, Benazzoug Y, Feldman L, Michel JB: Extracellular matrix remodeling in the vascular wall. Pathol Biol 2001, 49:326-332
8. Della Corte A, Quarto C, Bancone C, Castaldo C, Di Meglio F, Nurzynska D, De Santo LS, De Feo M, Scardone M, Montagnani S, Cotrufo M: Spatiotemporal patterns of smooth muscle cell changes in ascending aortic dilatation with bicuspid and tricuspid aortic valve stenosis: focus on cell-matrix signaling. J Thorac Cardiovasc Surg 2008, 135:8-18, 18 e11-12
9. Ihling C, Szombathy T, Nampoothiri K, Haendeler J, Beyersdorf F, Uhl M, Zeiher AM, Schaefer HE: Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation. Heart 1999, 82:286-293
10. Lopez-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW: Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 1997, 150:993-1007
11. Thompson RW, Liao S, Curci JA: Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron Artery Dis 1997, 8:623-631
12. Ikonomidis JS, Gibson WC, Gardner J, Sweterlitsch S, Thompson RP, Mukherjee R, Spinale FG: A murine model of thoracic aortic aneurysms. J Surg Res 2003, 115:157-163
13. Jones JA, Barbour JR, Lowry AS, Bouges S, Beck C, McClister DM, Jr., Mukherjee R, Ikonomidis JS: Spatiotemporal expression and localization of matrix metalloproteinase-9 in a murine model of thoracic aortic aneurysm. J Vasc Surg 2006, 44:1314-1321
14. Junqueira LC, Bignolas G, Brentani RR: Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979, 11:447-455
15. Fitch RM, Rutledge JC, Wang YX, Powers AF, Tseng JL, Clary T, Rubanyi GM: Synergistic effect of angiotensin II and nitric oxide synthase inhibitor in increasing aortic stiffness in mice. Am J Physiol Heart Circ Physiol 2006, 290:H1190-H1198
16. Michel JB, Heudes D, Michel O, Poitevin P, Philippe M, Scalbert E, Corman B, Levy BI: Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol 1994, 267:R124-R135
17. Akishima Y, Akasaka Y, Ishikawa Y, Lijun Z, Kiguchi H, Ito K, Itabe H, Ishii T: Role of macrophage and smooth muscle cell apoptosis in association with oxidized low-density lipoprotein in the atherosclerotic development. Mod Pathol 2005, 18:365-373
18. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR: Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006, 12:1075-1080
19. Marchand EL, Der Sarkissian S, Hamet P, deBlois D: Caspase-dependent cell death mediates the early phase of aortic hypertrophy regression in losartan-treated spontaneously hypertensive rats. Circ Res 2003, 92:777-784
20. Della Corte A, De Santo LS, Montagnani S, Quarto C, Romano G, Amarelli C, Scardone M, De Feo M, Cotrufo M, Caianiello G: Spatial patterns of matrix protein expression in dilated ascending aorta with aortic regurgitation: congenital bicuspid valve versus Marfan's syndrome. J Heart Valve Dis 2006, 15:20-27; discussion 27
21. Irizarry E, Newman KM, Gandhi RH, Nackman GB, Halpern V, Wishner S, Scholes JV, Tilson MD: Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J Surg Res 1993, 54:571-574
22. Raffetto JD, Khalil RA: Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008, 75:346-359
23. Agozzino L, Sante P, Ferraraccio F, Accardo M, De Feo M, De Santo LS, Nappi G, Agozzino M, Esposito S: Ascending aorta dilatation in aortic valve disease: morphological analysis of medial changes. Heart Vessels 2006, 21:213-220
24. Cotrufo M, Della Corte A, De Santo LS, Quarto C, De Feo M, Romano G, Amarelli C, Scardone M, Di Meglio F, Guerra G, Scarano M, Vitale S, Castaldo C, Montagnani S: Different patterns of extracellular matrix protein expression in the convexity and the concavity of the dilated aorta with bicuspid aortic valve: preliminary results. J Thorac Cardiovasc Surg 2005, 130:504-511
25. de Figueiredo Borges L, Jaldin RG, Dias RR, Stolf NA, Michel JB, Gutierrez PS: Collagen is reduced and disrupted in human aneurysms and dissections of ascending aorta. Hum Pathol 2008, 39:437-443
26. Barbour JR, Stroud RE, Lowry AS, Clark LL, Leone AM, Jones JA, Spinale FG, Ikonomidis JS: Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formation. J Thorac Cardiovasc Surg 2006, 132:788-795
27. Brower GL, Gardner JD, Forman MF, Murray DB, Voloshenyuk T, Levick SP, Janicki JS: The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg 2006, 30:604-610
28. Spinale FG: Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007, 87:1285-1342
29. Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR: Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation 2004, 110:3480-3487
30. Kowalewski R, Sobolewski K, Malkowski A, Wolanska M, Gacko M: Evaluation of enzymes involved in proteoglycan degradation in the wall of abdominal aortic aneurysms. J Vasc Res 2006, 43:95-100
31. Springer TA: Monoclonal antibody analysis of complex biological systems. Combination of cell hybridization and immunoadsorbents in a novel cascade procedure and its application to the macrophage cell surface. J Biol Chem 1981, 256:3833-3839
32. Springer T, Galfre G, Secher DS, Milstein C: Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 1979, 9:301-306
33. Goldsmith EC, Hoffman A, Morales MO, Potts JD, Price RL, McFadden A, Rice M, Borg TK: Organization of fibroblasts in the heart. Dev Dyn 2004, 230:787-794
34. Osborn M, Weber K: Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest 1983, 48:372-394
35. Rungger-Brandle E, Gabbiani G: The role of cytoskeletal and cytocontractile elements in pathologic processes. Am J Pathol 1983, 110:361-392
36. Skalli O, Schurch W, Seemayer T, Lagace R, Montandon D, Pittet B, Gabbiani G: Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest 1989, 60:275-285
37. Babu GJ, Warshaw DM, Periasamy M: Smooth muscle myosin heavy chain isoforms and their role in muscle physiology. Microsc Res Tech 2000, 50:532-540
38. Frangogiannis NG, Michael LH, Entman ML: Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc Res 2000, 48:89-100
39. Eyden B: The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 2008, 12:22-37
40. Gabbiani G: The biology of the myofibroblast. Kidney Int 1992, 41:530-532
41. Hinz B: Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007, 127:526-537
42. Schurch W, Seemayer TA, Gabbiani G: The myofibroblast: a quarter century after its discovery. Am J Surg Pathol 1998, 22:141-147
43. Frangogiannis NG: The mechanistic basis of infarct healing. Antioxid Redox Signal 2006, 8:1907-1939
44. Sakata N, Nabeshima K, Iwasaki H, Tashiro T, Uesugi N, Nakashima O, Ito H, Kawanami T, Furuya K, Kojima M: Possible involvement of myofibroblast in the development of inflammatory aortic aneurysm. Pathol Res Pract 2007, 203:21-29
45. Shi Y, O'Brien JE, Jr., Fard A, Zalewski A: Transforming growth factor-β1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol 1996, 16:1298-1305
46. Vaughan MB, Howard EW, Tomasek JJ: Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 2000, 257:180-189
47. Jones JA, Barbour JR, Stroud RE, Bouges S, Stephens SL, Spinale FG, Ikonomidis JS: Altered transforming growth factor-β signaling in a murine model of thoracic aortic aneurysm. J Vasc Res 2008, 45:457-468
48. Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, Fox JE, Mancini GM, Kambouris M, Gardella R, Facchetti F, Willems PJ, Forsyth R, Dietz HC, Barlati S, Colombi M, Loeys B, De Paepe A: Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet 2006, 38:452-457
49. Kresse H, Schonherr E: Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 2001, 189:266-274